AMCP Conference Panelists Decry ‘Innovation Reduction Act’

  • Apr 04, 2025

    The “well-intentioned” Inflation Reduction Act (IRA) of 2022 could cause more harm than good in the world of payers, pharmacies and drug development, according to experts who spoke at the 2025 Academy of Managed Care Pharmacy conference in Houston, held March 31 through April 3. 

    The IRA introduced a $2,000 cap on Medicare Part D beneficiaries’ out-of-pocket drug costs in the catastrophic phase of coverage, which took effect this year. When the cap is met, the remaining cost responsibility is shouldered by payers and drug manufacturers, which both are now paying a larger share of those costs than they did before the IRA. 

    Read more
    © 2024 MMIT
  • Jill Drachenberg

    Jill has been a reporter and editor since 2005, mainly focusing on business and health care. Before joining AIS Health, she was an editor for Relias Media (formerly AHC Media), focusing on topics such as case management, medical ethics, risk management, infection control, hospital management, and contraceptive technology. She has a B.A. in journalism from Georgia State University.

The Latest
Meet Our Reporters

Meet Our Reporters

×